Viacheslav Y. Kravtsov

Saint Petersburg, SPE, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Comparative Binding Analysis by Computational Methods and Quartz Crystal Microbalance: Case of hnRNPA2B1 Protein and Irinotecan Drug.

Comparative Binding Analysis by Computational Methods and Quartz Crystal Microbalance: Case of hnRNPA2B1 Protein and Irinotecan Drug.

Journal: Journal of chemical information and modeling

Published: February 23, 2026

hnRNP A2B1 as a promising therapeutic target for radiomodulatory drug development: evidence from computational and experimental studies.

hnRNP A2B1 as a promising therapeutic target for radiomodulatory drug development: evidence from computational and experimental studies.

Journal: Frontiers in pharmacology

Published: September 13, 2025

Computational Modeling of Chromoanagenesis- or Chromothripsis-Induced SNPs in Antiapoptotic Genes: Their Impact on Protein Structure and Function.

Computational Modeling of Chromoanagenesis- or Chromothripsis-Induced SNPs in Antiapoptotic Genes: Their Impact on Protein Structure and Function.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: August 30, 2025

Development of a Novel GABAB Receptor Modulator as an Alternative to Phenibut: Insights from Molecular Modeling and In Vivo Studies.

Development of a Novel GABAB Receptor Modulator as an Alternative to Phenibut: Insights from Molecular Modeling and In Vivo Studies.

Journal: Current neuropharmacology

Published: May 22, 2025

Effective Immobilization of hnRNPA2B1 Protein in a PEI Layer on a QCM Gold Electrode.

Effective Immobilization of hnRNPA2B1 Protein in a PEI Layer on a QCM Gold Electrode.

Journal: Langmuir : the ACS journal of surfaces and colloids

Published: March 26, 2025

Breaking Boundaries in Cancer Therapy: Harnessing Chromothripsis- Induced Mutations for Targeted BCL2 Protein Destabilization.

Breaking Boundaries in Cancer Therapy: Harnessing Chromothripsis- Induced Mutations for Targeted BCL2 Protein Destabilization.

Journal: Current drug discovery technologies

Published: January 30, 2025

Breaking Boundaries in Cancer Therapy: Harnessing Chromothripsisinduced Mutations for Targeted Bcl-2 Protein Destabilization.

Breaking Boundaries in Cancer Therapy: Harnessing Chromothripsisinduced Mutations for Targeted Bcl-2 Protein Destabilization.

Journal: Current drug discovery technologies

Published: January 30, 2025

Targeted Anti-Inflammatory Effects of Chloramphenicol via TLR4 Inhibition in Postoperative Hemorrhoid Treatment: A Clinico-Computational Cohort Study.

Targeted Anti-Inflammatory Effects of Chloramphenicol via TLR4 Inhibition in Postoperative Hemorrhoid Treatment: A Clinico-Computational Cohort Study.

Journal: Current medicinal chemistry

Published: January 06, 2025

Targeted Anti-Inflammatory Effects of Chloramphenicol via TLR4 Inhibition in Postoperative Hemorrhoid Treatment: A Clinico- Computational Cohort Study.

Targeted Anti-Inflammatory Effects of Chloramphenicol via TLR4 Inhibition in Postoperative Hemorrhoid Treatment: A Clinico- Computational Cohort Study.

Journal: Current medicinal chemistry

Published: January 06, 2025

Ergodic Manipulation of Genome Chaos: Innovative Strategies against Malignant Progression.

Ergodic Manipulation of Genome Chaos: Innovative Strategies against Malignant Progression.

Journal: Current cancer drug targets

Published: December 21, 2024

Discovery of Polyphenolic Compounds from Mangifera indica as Potent Therapeutics for Strongyloides stercoralis Infection via Computer-aided Drug Design.

Discovery of Polyphenolic Compounds from Mangifera indica as Potent Therapeutics for Strongyloides stercoralis Infection via Computer-aided Drug Design.

Journal: Current computer-aided drug design

Published: October 08, 2024

Perspectives on Ergodic Cancer Therapy Derived from Cloning Genome Chaos via In Vivo Rhabdomyosarcoma RA-2 Models: a Narrative Review.

Perspectives on Ergodic Cancer Therapy Derived from Cloning Genome Chaos via In Vivo Rhabdomyosarcoma RA-2 Models: a Narrative Review.

Journal: Current cancer drug targets

Published: March 28, 2024

Showing 1-12 of 21

Last Updated: 09/26/2026